Haemonetics (HAE) Return on Assets ROA from the second quarter of 2026 to second quarter of 2026 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 26 2026 to Sep 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Haemonetics Corporation  (NYSE: HAE)


Haemonetics's ROA from the second quarter of 2026 to the second quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Haemonetics's ROA in the second quarter of 2026?
Haemonetics Corporation achieved a return on average assets (ROA) of 3.86 % in its second quarter of 2026, this is above HAE's average return on assets of 3.56%.
Haemonetics Corporations assets during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROA has improved compared to 3.7% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 163 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 1019 to 1389.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 26 2026)
II. Quarter		 (Jun 27 2026)
I. Quarter		 (Mar 28 2026)
IV. Quarter		 (Dec 27 2025)
III. Quarter		 (Sep 27 2025)
II. Quarter
Y / Y Total Assets Change 15.42 % 12.19 % -2.01 % -4.66 % -3.25 %
Y / Y Net Income Change 19.7 % -3 % - 19.33 % 14.34 %
Net Income (TTM) in million 104 96 97 175 168
Return On Assets (TTM) 3.86 % 3.7 % 3.86 % 6.92 % 6.54 %
HAE's Total Ranking # 1389 # 1019 # 907 # 955 # 943
Total Assets (TTM) in million 2,812 2,757 2,396 2,807 2,437
Seq. Total Assets Change 2.02 % 15.05 % -14.65 % 15.2 % -0.83 %
Seq. Net Income Change 40.28 % - - 15.66 % 13.67 %

HAE's 5 Years Annual ROA >> Back to HAE Management Effectiveness >> Compare HAE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 46
Sector # 164
Overall # 1301

Return On Assets Statistics
High Average Low
9.89 %
3.56 %
-4.74 %
(Jul 02 2011)  





Financial Statements
Haemonetics's Assets $ 2,812 million HAE's Balance sheet
Haemonetics's Income $ 46 million Quarterly HAE's Income Statement
HAE's Income by Division See HAE's Income by Division



Annual Return On Assets (Mar 28 2026)
FY 2026		 (Mar 29 2025)
FY 2025		 (Mar 30 2024)
FY 2024		 (Apr 01 2023)
FY 2023		 (Apr 02 2022)
FY 2022
Y / Y Total Assets Change -2.01 % 11.67 % 13.35 % 4.07 % 2.26 %
Total Assets in million 2,396 2,445 2,189 1,932 1,856
Y / Y Net Income Change -41.97 % 42.64 % 1.87 % 166.05 % -45.42 %
Net Income in million 97 168 118 115 43
Annual Return On Assets 4.06 % 6.86 % 5.37 % 5.97 % 2.34 %

HAE's 5 Years Annual ROA >> Back to HAE Management Effectiveness >> Compare HAE ROA to its Competitors



Comment on HAE's ROA in the fiscal year ending 2026
In the fiscal year 2026 Haemonetics's ROA decreased compared to previous year to 4.06 %, due to deterioration of net income -41.97 % to $97.31 million, from $167.68 million a year ago, as HAE's assets were $2,395.93 million.


More Return On Assets Ratios
HAE's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HAE's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HAE's Competitors
Subscribers only: Roa for Haemonetics's Suppliers
Subscribers only: Return On Assets for HAE's Customers

You may also want to know
HAE's Roi HAE's Inventory Turnover Ratio HAE's Growth Rates HAE's Dividend Comparisons
HAE's Profitability Ratios HAE's Asset Turnover Ratio HAE's Dividend Growth
HAE's Roe HAE's Valuation Ratios HAE's Financial Strength Ratios HAE's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 26 2026, within Healthcare Sector ROA
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %
Johnson and Johnson  8.06 %
Pacific Health Care Organization Inc  7.83 %
Boston Scientific Corporation  7.82 %
Ani Pharmaceuticals Inc  7.77 %
Stryker Corp  7.66 %
Abbvie Inc   7.48 %
Ensign Group Inc  7.00 %
Pediatrix Medical Group Inc   6.99 %
Quest Diagnostics Inc  6.96 %
Davita Inc   6.65 %
Brightspring Health Services Inc   6.60 %
Ge Healthcare Technologies Inc   5.85 %
Merit Medical Systems Inc  5.72 %
Incyte Corporation  5.48 %
Labcorp Holdings Inc   5.36 %
Sotera Health Company  5.26 %
Black Hawk Acquisition Corporation  5.19 %
Pacs Group Inc   4.87 %
Iqvia Holdings Inc   4.65 %
Teleflex Incorporated  4.54 %
Haemonetics Corporation  4.30 %
Henry Schein Inc   3.84 %

Date modified: 2026-11-08T19:25:12+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.